Amneal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.

About AMRX

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. 

CEO
Chintu Patel
CEOChintu Patel
Employees
8,500
Employees8,500
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2002
Founded2002
Employees
8,500
Employees8,500

AMRX Key Statistics

Market cap
7.45B
Market cap7.45B
Price-Earnings ratio
52.49
Price-Earnings ratio52.49
Dividend yield
—
Dividend yield—
Average volume
3.91M
Average volume3.91M
High today
$21.80
High today$21.80
Low today
$21.30
Low today$21.30
Open price
$21.49
Open price$21.49
Volume
1.65M
Volume1.65M
52 Week high
$22.07
52 Week high$22.07
52 Week low
$11.39
52 Week low$11.39

Stock Snapshot

With a market cap of 7.45B, Amneal Pharmaceuticals(AMRX) trades at $21.38. The stock has a price-to-earnings ratio of 52.49.

As of 2026-11-15, Amneal Pharmaceuticals(AMRX) stock has fluctuated between $21.30 and $21.80. The current price stands at $21.38, placing the stock +0.4% above today's low and -1.9% off the high.

The Amneal Pharmaceuticals(AMRX)'s current trading volume is 1.65M, compared to an average daily volume of 3.91M.

In the last year, Amneal Pharmaceuticals(AMRX) shares hit a 52-week high of $22.07 and a 52-week low of $11.39.

In the last year, Amneal Pharmaceuticals(AMRX) shares hit a 52-week high of $22.07 and a 52-week low of $11.39.

AMRX News

Simply Wall St 3d
Amneal Stock Looks Above Fair Value As Its 397% Run Continues

has delivered a striking share price run in recent years, which naturally puts the focus on whether the current level is still backed by the earnings the busine...

Amneal Stock Looks Above Fair Value As Its 397% Run Continues
Investing.com 4d
Amneal Pharmaceuticals stock hits 52-week high at $21.74 - Investing.com

...

Amneal Pharmaceuticals stock hits 52-week high at $21.74 - Investing.com
Simply Wall St 5d
Will Raised Revenue Guidance Change Amneal Pharmaceuticals Stock Narrative

Amneal Pharmaceuticals reported third quarter 2026 sales of US$862.68 million and a net loss of US$21.7 million, alongside US$14.81 million of asset impairment...

Will Raised Revenue Guidance Change Amneal Pharmaceuticals Stock Narrative

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

More AMRX News

Simply Wall St 7d
Amneal Pharmaceuticals Lifts 2026 Guidance, Is The 12% Undervalued View Enough?

Why Amneal Pharmaceuticals Is Back on Investors' Radar Amneal Pharmaceuticals (AMRX) has drawn fresh scrutiny after raising its full year 2026 revenue outlook,...

Amneal Pharmaceuticals Lifts 2026 Guidance, Is The 12% Undervalued View Enough?
TipRanks 7d
Amneal Earnings Call Signals Strong Growth Ahead

Amneal Pharma ((AMRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Amneal Pharmaceuticals delivered a strongly positive earning...

People also own

Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.